salmeterol xinafoate has been researched along with Allergic Bronchopulmonary Aspergilloses in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bond, RA; Corry, DB; Frazier, V; Kheradmand, F; Kim, C; Kim, JJ; Knight, JM; Luong, A; Mak, G; Mandal, PK; McDermott, C; McMurray, JS; Millien, VO; Milner, JD; Porter, P; Qian, Y; Roberts, L; Shaw, J; Song, LZ; You, R; Yuan, X; Zhang, Y | 1 |
1 other study(ies) available for salmeterol xinafoate and Allergic Bronchopulmonary Aspergilloses
Article | Year |
---|---|
Long-Acting Beta Agonists Enhance Allergic Airway Disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Anti-Asthmatic Agents; Arrestins; Aspergillosis, Allergic Bronchopulmonary; Aspergillus niger; Asthma; beta-Arrestins; Bronchoconstriction; Carbazoles; Carvedilol; Disease Models, Animal; Female; Formoterol Fumarate; Gene Expression; Humans; Lung; Mice; Mice, Knockout; Peptidomimetics; Propanolamines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; STAT6 Transcription Factor | 2015 |